-

Kirby McInerney LLP Alerts Investors Who Acquired Pentair plc PNR Securities Between March 11, 2025 and July 14, 2026 of Pending Lawsuit

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds Pentair plc (“Pentair” or the “Company”) (NYSE: PNR) investors of the October 2, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is The Lawsuit About?

The lawsuit has been filed on behalf of investors who purchased securities during the period of March 11, 2025 and July 14, 2026, inclusive (“the Class Period”). The lawsuit alleges that Pentair made materially false and/or misleading statements and failed to disclose to investors: (i) that there was significant destocking of inventory in the Pool channel; and (ii) as a result, the Company’s sales and operating income were adversely affected.

On February 3, 2026, Pentair announced its fourth quarter and full year 2026 financial results, revealing that Pentair’s net sales were on track to grow only 1% to 2% for its first fiscal quarter of 2026, missing analyst consensus estimates by tens of millions of dollars. During the related earnings call, Pentair disclosed that net sales growth in its critical Pool business had been flat. Pentair concurrently announced that the Company’s Chief Transformation Officer & Chief Supply Officer, Steve Pilla, was departing. On this news, Pentair’s stock price fell $10.72, or over 10%, to close at $94.79 per share on February 3, 2026.

Then, on April 28, 2026, Pentair announced its first quarter 2026 financial results, revealing that the Company had cut its annual net sales guidance for Pool to a range of 1% to 3% net sales growth. During the related earnings call, CFO Nicholas J. Brazis further revealed that the downward revision reflected the need of channel partners to “reduce purchases in Q2 and Q3” in light of “sell-through dynamics” experienced in the first quarter. On this news, Pentair’s stock price fell $11.43, or more than 12%, to close at $ 80.84 per share on April 29, 2026.

On July 14, 2026, Pentair released its preliminary second quarter 2026 financial results, revealing that “the [Company] estimates that the destocking of inventory in the Pool channel negatively impacted Pool segment sales by approximately $170 million and Pool segment income by approximately $105 million.” As a result, second quarter 2026 sales were expected to be “down 17 percent versus previous guide of up approximately 1 percent,” and full year 2026 sales were expected to be “down approximately 4 percent to 7 percent versus previous guide of up 2 percent to 4 percent.” The Company explained that second quarter performance “was impacted by a decline in Pool sales largely attributed to a more pronounced inventory realignment with major channel partners than previously estimated and worsening business conditions, including higher interest rates and inflation.” The Company also announced the departure of its Chief Financial Officer, effective immediately. On this news, Pentair’s stock price fell $11.35, or 15%, to close at $64.33 per share on July 15, 2026.

[CLICK HERE TO LEARN MORE ABOUT THE LAWSUIT]

What Should I Do?

If you purchased or otherwise acquired Pentair securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

What is the Lead Plaintiff Deadline?

Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements here.

[LEARN MORE ABOUT THE LEAD PLAINTIFF PROCESS]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP

NYSE:PNR

Release Versions
$Cashtags

Contacts

More News From Kirby McInerney LLP

Securities Class Action Filed Against FuelCell Energy – FCEL Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired FuelCell Energy, Inc. (“FuelCell” or the “Company”) (NASDAQ: FCEL) securities between June 24, 2026 and September 1, 2026, inclusive (“the Class Period”). If you suffered a loss on your FuelCell investments, you have until November 10, 2026 to request lead plaintiff appointment. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] Investors are encouraged...

Securities Class Action Filed Against Lincoln Educational Services Corporation – LINC Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Lincoln Educational Services Corporation (“Lincoln” or the “Company”) (NASDAQ: LINC) securities between May 11, 2026 and August 9, 2026, inclusive (“the Class Period”). If you suffered a loss on your Lincoln investments, you have until November 10, 2026 to request lead plaintiff appointment.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]Investors are e...

UNCY INVESTOR REMINDER: Unicycive Therapeutics, Inc. Investors Have Until November 2, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.Investors have until November 2, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after...
Back to Newsroom